ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Scope & Guideline

Connecting research and practice in Alzheimer’s and geriatric health.

Introduction

Explore the comprehensive scope of ALZHEIMER DISEASE & ASSOCIATED DISORDERS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore ALZHEIMER DISEASE & ASSOCIATED DISORDERS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0893-0341
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1987 to 2024
AbbreviationALZ DIS ASSOC DIS / Alzheimer Dis. Assoc. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Alzheimer Disease & Associated Disorders' focuses on advancing the understanding of Alzheimer’s disease and related disorders. It aims to publish high-quality research that covers a wide spectrum of topics related to cognitive decline, dementia, and the various factors affecting these conditions.
  1. Cognitive Function and Dementia Assessment:
    Research that explores various methodologies for assessing cognitive function, including neuropsychological tests and imaging techniques, to better understand dementia progression.
  2. Biomarkers and Pathophysiology:
    Studies focusing on identifying biomarkers for Alzheimer's disease and related disorders, as well as understanding the underlying biological mechanisms contributing to neurodegeneration.
  3. Impact of Lifestyle and Environmental Factors:
    Investigations into how lifestyle choices, such as physical activity and diet, as well as environmental factors, influence cognitive health and the risk of dementia.
  4. Caregiver Studies and Psychosocial Aspects:
    Research examining the burden and quality of life for caregivers of Alzheimer’s patients, and the psychosocial impacts of dementia on individuals and families.
  5. Clinical Interventions and Therapeutics:
    Studies investigating various therapeutic approaches, including pharmacological and non-pharmacological interventions, aimed at managing or treating Alzheimer’s disease and related disorders.
  6. Diversity and Health Disparities:
    Research that highlights the differences in Alzheimer’s disease prevalence and outcomes among diverse populations, addressing health disparities in care and access.
Recent publications in 'Alzheimer Disease & Associated Disorders' reveal several emerging themes that reflect the evolving landscape of research in the field. These trends indicate areas of growing interest and relevance.
  1. Holistic and Multidisciplinary Approaches:
    There is an increasing trend towards studies that incorporate multidisciplinary perspectives, including psychological, social, and environmental factors in understanding and managing Alzheimer’s disease.
  2. Prevention and Early Intervention Strategies:
    Research focused on identifying early signs of cognitive decline and implementing preventive strategies is gaining prominence, highlighting the importance of early detection and intervention.
  3. Technology in Dementia Care:
    The use of technology, including digital health tools and telemedicine, in dementia care and research is on the rise, reflecting a shift towards innovative solutions for patient management and research methodologies.
  4. Cultural and Ethnic Studies in Dementia:
    Emerging research is increasingly examining the cultural and ethnic dimensions of dementia care, addressing how cultural factors influence perceptions, diagnosis, and treatment of Alzheimer’s disease.
  5. Neuropsychiatric Symptoms and Behavioral Interventions:
    There is heightened interest in exploring neuropsychiatric symptoms associated with dementia and the development of behavioral interventions to manage these symptoms effectively.

Declining or Waning

While the journal continues to explore a wide range of topics, some areas have shown a decline in focus over recent years. These waning themes may reflect shifts in research priorities or emerging interests in the field.
  1. Genetic Studies in Alzheimer’s Disease:
    Although genetic research remains important, the frequency of publications focusing solely on genetic variants related to Alzheimer’s has decreased, possibly due to a saturation of findings and a shift towards integrative approaches that consider environmental and lifestyle factors.
  2. Animal Models in Alzheimer Research:
    There has been a noticeable decline in studies exclusively using animal models to investigate Alzheimer’s disease, indicating a potential shift towards human-centric research and clinical studies.
  3. Traditional Pharmacological Approaches:
    The focus on traditional pharmacological treatments for Alzheimer’s disease is waning as researchers increasingly explore alternative and complementary therapies, including lifestyle interventions and holistic approaches.

Similar Journals

GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry

Fostering Insights into the Psychology of Aging
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 1662-9647Frequency: 4 issues/year

GeroPsych - The Journal of Gerontopsychology and Geriatric Psychiatry, published by HOGREFE AG, stands as an essential academic resource in the evolving fields of gerontology and geriatric psychiatry. With a commitment to advancing the understanding of psychological well-being in older adults, the journal provides a platform for high-quality research, discussion, and innovation that caters to researchers, practitioners, and students alike. Although currently not an open-access publication, GeroPsych ensures accessibility through various academic libraries and institutions, fostering a collaborative approach to the complexities of aging and mental health. Recognized within the Q3 category for Geriatrics and Gerontology, and with its impact reflected in Scopus rankings, this journal plays a pivotal role in informing best practices and shaping policies within the interdisciplinary landscape of geriatric care. Spanning research from 2010 to 2024, GeroPsych is positioned as a leading journal for those committed to improving the mental health and psychological resilience of the aging population.

JPAD-Journal of Prevention of Alzheimers Disease

Innovative Research for a Brighter Memory Future
Publisher: SPRINGER BASEL AGISSN: 2274-5807Frequency: 4 issues/year

JPAD - Journal of Prevention of Alzheimer’s Disease, published by Springer Basel AG, is a premier academic journal dedicated to advancing research in the critical field of Alzheimer’s disease prevention. Its impactful contributions to the fields of neurology, psychiatry, and mental health have led it to achieve a Q1 ranking in multiple categories, including neurology (clinical) and psychiatry and mental health. Since its inception in 2017, JPAD has become an essential platform for researchers and professionals aiming to stay at the forefront of developments in Alzheimer’s disease research, prevention strategies, and innovative therapies. The journal provides a valuable open access option for disseminating high-quality research to a global audience, enhancing its visibility and impact. With its strategic focus and rigorous peer-review process, JPAD is committed to fostering collaboration and knowledge exchange among scientists, clinicians, and practitioners, ultimately contributing to the global effort to combat Alzheimer's disease.

AGING & MENTAL HEALTH

Unraveling the Complexities of Aging and Mind
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1360-7863Frequency: 12 issues/year

AGING & MENTAL HEALTH, published by Routledge Journals, Taylor & Francis Ltd, is a leading academic journal that focuses on the dynamic intersection of aging and mental health, critically addressing issues pertinent to geriatric psychology and psychiatry. Established in 1997, this journal covers a wide range of topics including mental health disorders in older populations, cognitive decline, and social implications of aging. With an impressive reputation, it currently ranks in the Q1 category in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health, showcasing its significant contribution to these fields. The journal is recognized for its high-quality, peer-reviewed research and holds esteemed positions in Scopus rankings, emphasizing its relevance and impact in psychiatric nursing and gerontology. While it does not offer open access, AGING & MENTAL HEALTH remains a vital resource for researchers, professionals, and students dedicated to advancing our understanding of mental health in the aging population.

JOURNAL OF ALZHEIMERS DISEASE

Exploring the complexities of cognitive decline.
Publisher: IOS PRESSISSN: 1387-2877Frequency: 24 issues/year

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

American Journal of Alzheimers Disease and Other Dementias

Connecting researchers and clinicians for impactful discoveries.
Publisher: SAGE PUBLICATIONS INCISSN: 1533-3175Frequency: 81 issues/year

The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Fostering interdisciplinary dialogue in dementia research.
Publisher: KARGERISSN: 1420-8008Frequency: 6 issues/year

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

AGING NEUROPSYCHOLOGY AND COGNITION

Advancing understanding of cognitive aging.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1382-5585Frequency: 6 issues/year

AGING NEUROPSYCHOLOGY AND COGNITION, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading scholarly journal that spans the interdisciplinary fields of psychology, neuropsychology, and gerontology. With a strong focus on understanding aging processes and cognitive function, this journal serves as a critical platform for researchers, clinicians, and students dedicated to advancing knowledge in the realm of cognitive aging. The journal, established in 1994, presents high-quality research articles, comprehensive reviews, and innovative studies that contribute to the discourse surrounding mental health and aging. Notably, it has been recognized with a 2023 Q2 ranking in Experimental and Cognitive Psychology and Neuropsychology categories, reflecting its significant impact within these domains. The journal includes open access options, making it widely accessible to a global audience. Researchers interested in the latest findings and theoretical developments in aging neuropsychology will find this journal an invaluable resource, further enhanced by its robust Scopus rankings and commitment to academic excellence through 2024 and beyond.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Pioneering research at the intersection of aging and psychiatry.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging

Unlocking the Secrets of the Mind through Advanced Research
Publisher: ELSEVIERISSN: 2451-9022Frequency: 12 issues/year

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

Alzheimers & Dementia

Transforming understanding of dementia through innovative research.
Publisher: WILEYISSN: 1552-5260Frequency: 12 issues/year

Alzheimers & Dementia is a premier journal published by WILEY that focuses on the latest advancements in understanding, diagnosing, and treating Alzheimer's disease and other dementias. With an ISSN of 1552-5260 and an E-ISSN of 1552-5279, this influential journal boasts a commendable impact factor and ranks in the Q1 category across several disciplines, including *Cellular and Molecular Neuroscience*, *Geriatrics and Gerontology*, and *Neurology (Clinical)*. By publishing cutting-edge research, systematic reviews, and innovative clinical trials, Alzheimers & Dementia aims to bridge the gap between basic neuroscience and clinical practice, offering valuable insights into the etiology, epidemiology, and management of dementia-related disorders. The journal is hosted in the United States and operates under a balanced access model, providing essential resources for researchers, healthcare professionals, and students dedicated to tackling the challenges posed by these neurodegenerative diseases. Available online, it plays a pivotal role in shaping current and future research directions in the vibrant field of dementia studies.